Expression of an active Akt, reversed wortmannin- and dexamethasone-induced apoptosis and growth inhibition in PTEN-null myeloma lines, suggesting that Akt lies downstream of PI3K for PTEN-null myeloma survival and dexamethasone resistance [374]. This evidence concerns the gene AKT1 and plasma cell myeloma.